A Phase 4, Randomized, Open Label, Multicenter, Prospective Comparative Study to Evaluate the Efficacy and Safety of Edoxaban or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-valvular Atrial Fibrillation

Trial Profile

A Phase 4, Randomized, Open Label, Multicenter, Prospective Comparative Study to Evaluate the Efficacy and Safety of Edoxaban or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-valvular Atrial Fibrillation

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Mar 2017

At a glance

  • Drugs Edoxaban (Primary) ; Warfarin
  • Indications Thromboembolism
  • Focus Therapeutic Use
  • Acronyms ENTICED-AF
  • Most Recent Events

    • 08 Mar 2017 Status changed from recruiting to discontinued.
    • 18 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 01 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top